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Summary
Clonally expanded mitochondrial DNA (mtDNA) deletions
accumulate with age in human substantia nigra (SN) and
high levels cause respiratory chain deﬁciency. In other
human tissues, mtDNA point mutations clonally expand
with age. Here, the abundance of mtDNA point mutations
within single SN neurons from aged controls was investi-
gated. From 31 single cytochrome c oxidase normal SN
neurons, only one clonally expanded mtDNA point muta-
tion was identiﬁed, suggesting in these neurons mtDNA
point mutations occur rarely, whereas mtDNA deletions
are frequently observed. This contrasts observations in
mitotic tissues and suggests that different forms of
mtDNA maintenance may exist in these two cell types.
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The mitochondrial genome is present in multiple copies, the
number varying depending on the energy requirement of the
cell. Mitochondrial DNA encodes key respiratory chain proteins,
as well as RNA machinery required for intra-mitochondrial
protein synthesis (Anderson et al., 1981). Mitochondrial DNA
defects are an important cause of mitochondrial disease with an
incidence of 1 in 10 000 adults clinically affected in the UK
(Schaefer et al., 2008). Although patient symptoms are variable,
severe and progressive neurological problems are a common
feature (Taylor & Turnbull, 2005).
Mitochondrial DNA mutations accumulate with age in many
tissues from human subjects (Liu et al., 1998; Fayet et al., 2002;
Nekhaeva et al., 2002; Taylor et al., 2003), although their contri-
bution to the human aging process remains uncertain. Both
mtDNApointmutationsandlarge-scaledeletionsclonallyexpand
to high levels (> 60%) leading to respiratory chain deﬁciency.
Support for a direct role for mtDNA mutations in aging resulted
from the generation of mouse models with a proof-reading deﬁ-
cient version of PolgA; these mice have high levels of mtDNA
mutations and develop a premature aging phenotype (Trifunovic
etal.,2004;Kujothetal.,2005;Vermulstetal.,2008).
Although both mtDNA deletions and point mutations are
observed in human cells, few studies have examined the pres-
ence of both in the same tissue. This may give insight into the
mechanisms by which they arise and clonally expand. We previ-
ously detected high levels of mtDNA deletions in substantia
nigra (SN) neurons from aged humans (Bender et al., 2006;
Krishnan et al., 2008; Reeve et al., 2008). In this study, we
wished to determine if these cells also contained clonally
expanded mtDNA point mutations.
Frozen midbrain sections were cut at 20 lm from ﬁve elderly
controls (Table 1). Mitochondrial dysfunction was determined
using sequential histochemical staining for the activities of cyto-
chrome c oxidase (COX) and succinate dehydrogenase (Brierley
et al., 1998). This revealed the presence of both COX normal
and deﬁcient SN neurons. Single COX normal cells were chosen
for analysis to allow comparison with mtDNA deletion levels
from our previous study (Bender et al., 2006).
The entire mtDNA was sequenced from 31 single SN neurons
as previously described (Taylor et al., 2001). Analysis of single
cell mtDNA sequences is problematic as highlighted previously
(Bandelt et al., 2008). Low mtDNA copy number in single cells
can result in contamination from nuclear pseudogenes or result
in PCR-induced errors. To ensure detection of only true clonally
expanded mutations, we re-sequenced all putative mutations
with DNA from the initial cell lysate; repeating the second-round
PCR, to conﬁrm the presence of a mutation by at least two,
separate PCR reactions. Following re-sequencing, we excluded
Correspondence
Dr Amy Reeve or Prof. D.M. Turnbull, Mitochondrial Research Group,
Newcastle University Centre for Brain Ageing and Vitality, Institute for
Ageing and Health, The Medical School, Newcastle University, Newcastle
upon Tyne, NE2 4HH, UK. Tel.: +44(0)1912228565;
fax: +44(0)1912228553; e-mail: a.k.reeve@ncl.ac.uk; d.m.turnbull@ncl.ac.uk
Accepted for publication 19 May 2009
Re-use of this article is permitted in accordance with the Terms and Conditions
set outat http://www3.interscience.wiley.com/authorresources/onlineopen.html
496 ª 2009 The Authors
Journal compilation ª Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2009
Aging Cell (2009) 8, pp496–498 Doi:10.1111/j.1474-9726.2009.00492.x
A
g
i
n
g
 
C
e
l
l10 mutations detected only on the initial PCR reaction. None
were recognized polymorphisms, suggesting the mutations
arose during PCR ampliﬁcation.
In total, we analysed 31 cells (513 639 bp). Germline poly-
morphisms were found in all cells from each subject. All changes
from the revised Cambridge Reference Sequence (Andrews
et al., 1999) (n = 730) were recognized polymorphic variants
(MITOMAP, 2009, Ingman & Gyllensten, 2006), permitting the
determination of mitochondrial haplogroups, for all subjects
(Table 1).
True clonally expanded point mutations were those present
only once in a single cell from an individual. Using these criteria,
wedetectedonly oneclonally expanded pointmutation (Table 1,
Fig. 1A). This m.5480A>C transversion found within the MTND2
gene, NADH ubiquinone oxidoreductase (complex I) subunit 2,
was synonymous and was heteroplasmic (30%) based on the
relative abundance of peaks in the sequence chromatogram.
This shows that clonal expansion of mtDNA point mutations is a
rare event in single SN neurons, consistent with previous data
from a small number of COX-deﬁcient cells (Bender et al.,
2006). The single clonally expanded point mutation detected
does not confer an amino acid change and is therefore unlikely
to be pathogenic. Based on these data, only 3% (1⁄31) of SN
neurons from the elderly subjects harbour a clonally expanded
point mutation, a very different scenario to mtDNA deletions,
where high levels of deletions were detected in COX normal
neurons from the same subjects (Table 1) and other elderly
subjects (Bender et al., 2006; Kraytsberg et al., 2006).
Both mitotic and postmitotic cells show clonal expansion of
mtDNA mutations with age, but it appears that there are
marked differences in the type of mutations detected. In buccal
epithelium cells and cardiomyocytes, clonally expanded mtDNA
point mutations have been documented; however, mtDNA dele-
tions were only detected in the cardiomyocytes (Bodyak et al.,
2001; Nekhaeva et al., 2002). In a separate study, in three differ-
ent tissues (skeletal muscle, heart and kidney), the 4977 bp
mtDNA deletion and an m.3243 A>G point mutation accumu-
lated with age. However, deletion levels were much higher in
skeletal muscle and point mutation accumulation occurred
earlier in the kidney and heart reaching higher levels than in
skeletal muscle (Liu et al., 1998). These studies imply that there
is preferential formation and⁄or accumulation of mtDNA point
mutations in mitotic tissues, whereas, mtDNA deletions accu-
mulate in postmitotic tissues (Fig. 1B).
Mitochondrial DNA replication occurs in postmitotic cells,
even though the cell cycle is suspended. The rate of mtDNA
turnover remains unknown, but it is thought to be much slower
in neurons than in dividing cells (Wang et al., 1997). Substantia
nigra neurons are particularly vulnerable to reactive oxygen
species damage, due in part to their high iron content and
through dopamine metabolism (Halliwell, 1992). Thus the high
levels of mtDNA deletions are most likely to be caused during
repair of the reactive oxygen species damage (Krishnan et al.,
2008). In mitotic tissues where cell turnover occurs more
frequently, mtDNA mutations are more likely to be generated
by replication errors (Fig. 1B).
Table 1 Table showing the details of the subjects used in this study
Subject
number Age
pm
delay (h) Sex
mtDNA
haplogroup Haplogroup markers
Percentage COX-deﬁcient
neurons in the SN
(Bender et al., 2006)
Percentage deletion
from 25 COX normal
neurons (Bender
et al., 2006)
1 75 30 M K m.3480A>G, m.9698T>C, m.10550A>G, m.11299T>C 0.61 40
2 72 28 F J m.11251A>G, m.12612A>G, m.13708G>A, m.15452C>A 0.35 45
3 75 9 F H2 m.1438A>G, m.4769A>G, m.8860A>G, m.15326A>G 0.26 42
4 81 29 F H2 m.1438A>G, m.4769A>G, m.8860A>G, m.15326A>G 0.12 33
5 89 27 M X m.6221T>C, m.6371C>T, m.13996A>G, m.14470T>C 0.42 56
pm, post mortem; COX, cytochrome c oxidase; SN, substantia nigra.
(A) (B)
Fig. 1 (A) Sequence electropherogram of the clonally expanded point mutation detected within the SN neurons. (B) Flow diagram to illustrate how different
mtDNA mutations may be preferentially formed in mitotic and postmitotic tissues. Both mutation types lead to mitochondrial dysfunction with age.
ROS = Reactive oxygen species.
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497In conclusion, we have described low levels of clonally
expanded point mutations in SN neurons, which contrast the
high levels of mtDNA deletions previously reported. This further
supports the difference in mtDNA mutation types detected
between mitotic and postmitotic cells, and implies that different
mechanisms of mtDNA maintenance exist within different cell
types.
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